APUS
Apimeds Pharmaceuticals US, Inc.
Going-concern doubt
— flagged May 26, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company’s ability to continue as a going concern. These condensed consolidated financial statements do not contain any adjustments that might result from the outcome of this uncertainty.”View the 10-Q filed May 26, 2026
Company with tickers: APUS
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2025-12-22 | 6,423 | 53,001 | 59,424 | 100.0% |
| 2025-12-29 | 3,574 | 56,661 | 60,235 | 100.0% |
| 2026-01-05 | 5,423 | 38,329 | 43,752 | 100.0% |
| 2026-01-12 | 11,765 | 163,757 | 175,522 | 100.0% |
| 2026-01-19 | 49,957 | 1,091,324 | 1,141,281 | 100.0% |
| 2026-01-26 | 21,010 | 424,053 | 445,063 | 100.0% |
| 2026-02-02 | 16,260 | 152,670 | 168,930 | 100.0% |
| 2026-02-09 | 20,353 | 674,215 | 694,568 | 100.0% |
| 2026-02-16 | 52,913 | 1,440,166 | 1,493,079 | 100.0% |
| 2026-02-23 | 5,143 | 114,104 | 119,247 | 100.0% |
| 2026-03-02 | 5,329 | 82,704 | 88,033 | 100.0% |
| 2026-03-09 | 5,971 | 288,409 | 294,380 | 100.0% |
| 2026-03-16 | 46,372 | 600,339 | 646,711 | 100.0% |
| 2026-03-23 | 25,911 | 338,247 | 364,158 | 100.0% |
| 2026-03-30 | 4,301 | 45,936 | 50,237 | 49.7% |
| 2026-05-04 | 276,610 | 2,673,201 | 2,949,811 | 44.8% |
Showing 1–16 of 16 weeks